KISSEI PHARMACEUTICAL CO.,LTD.
Develops innovative drugs for urology, renal diseases, and rare or intractable diseases.
4547 | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 松本市芳野１９番４８号
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Kissei Pharmaceutical Co., Ltd. is a research-driven pharmaceutical company engaged in the development, manufacturing, and commercialization of innovative medicines. The company strategically focuses its research and development efforts on specific therapeutic areas, including urology, renal diseases and dialysis, and rare or intractable diseases. Its business model integrates in-house drug discovery with strategic partnerships, such as in-licensing and out-licensing agreements, to build a robust product pipeline. Kissei's portfolio comprises both specialty and generic drugs, aiming to address unmet medical needs and contribute to the health of people globally.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for KISSEI PHARMACEUTICAL CO.,LTD. and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-27 06:00 |
Regulatory News Service
臨時報告書
|
Japanese | 23.3 KB | |
| 2025-06-24 06:01 |
Regulatory News Service
確認書
|
Japanese | 9.0 KB | |
| 2025-06-24 06:01 |
Regulatory News Service
内部統制報告書－第80期(2024/04/01－2025/03/31)
|
Japanese | 25.5 KB | |
| 2025-06-24 06:00 |
Annual Report
有価証券報告書－第80期(2024/04/01－2025/03/31)
|
Japanese | 1.5 MB | |
| 2025-06-11 06:00 |
Transaction in Own Shares
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 22.6 KB | |
| 2024-12-27 08:00 |
Major Shareholding Notification
大量保有報告書
|
Japanese | 38.5 KB | |
| 2024-12-13 05:00 |
Transaction in Own Shares
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 24.9 KB | |
| 2024-11-13 05:01 |
Regulatory News Service
確認書
|
Japanese | 9.0 KB | |
| 2024-11-13 05:00 |
Interim Report
半期報告書－第80期(2024/04/01－2025/03/31)
|
Japanese | 240.5 KB | |
| 2024-06-28 06:00 |
Regulatory News Service
臨時報告書
|
Japanese | 29.4 KB | |
| 2024-06-25 06:01 |
Regulatory News Service
内部統制報告書－第79期(2023/04/01－2024/03/31)
|
Japanese | 23.8 KB | |
| 2024-06-25 06:00 |
Regulatory News Service
確認書
|
Japanese | 9.0 KB | |
| 2024-06-25 06:00 |
Annual Report
有価証券報告書－第79期(2023/04/01－2024/03/31)
|
Japanese | 1.5 MB | |
| 2024-02-13 05:00 |
Regulatory News Service
確認書
|
Japanese | 9.0 KB | |
| 2024-02-13 05:00 |
Quarterly Report
四半期報告書－第79期第3四半期(2023/10/01－2023/12/31)
|
Japanese | 193.7 KB |
Automate Your Workflow. Get a real-time feed of all KISSEI PHARMACEUTICAL CO.,LTD. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for KISSEI PHARMACEUTICAL CO.,LTD. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}
